Pages
Armed Forces Community Staff Network
Supporting DCHS in the delivery of the Armed Forces Covenant Commitments
Five-star salon experience for Ilkeston patients
https://dchs.nhs.uk/news/five-star-salon-experience-ilkeston-patients
Consultation on mileage rates
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/consultation-mileage-rates
Files
Understanding Diabetes Education (L349)
Understanding Diabetes Education (L349)
Disclosure Ref 2025120 - Federated Data Platform.pdf
Disclosure Ref 2025120 relating to Federated Data Platform
Disclosure Ref 2025109 - Hospital admissions relating to sunbeds .pdf
FOI disclosure ref 2025/109 relating to hospital admissions related to sunbed injuries
Appendix 3 Redeployment Role Application Form.docx
Disclosure Ref 2025191 - Contact details for Decontamination & Infection Control leads .pdf
FOI disclosure relating to contact details for DCHS Decontamination Lead, Infection Control Lead, Endoscopy Decontamination Manager and Estates Manager
Disclosure Ref 2024187 - Complaints of discrimination reported in 2021 to 2023.pdf
Freedom of Information disclosure ref 2024187 relating to complaints of discrimination reported in 2021 to 2023
Disclosure ref 2024267 - invoices relating to Bolsover hospital.pdf
Freedom of information disclosure relating to Invoices, including supplier, value and dates for medical gases supplied to Bolsover community since 2019 to date of FOI request
Disclosure Ref 2024245 - Collabrative working with pharmaceutical companies.doc
Disclosure Ref 2024245 - Collaborative working with pharmaceutical companies
Disclosure Ref 2025296 - Permanent medical (e.g., Consultant or Specialty Doctor level) Recruitment Data.doc
Freedom of information disclosure relating to details of unfilled permanent medical vacancies, the number of permanent medical appointments made in the past 12 months, and the contact details of the person responsible for permanent medical recruitment.
Disclosure Ref 2025325 - Myeloma patients & specific drugs used.doc
Freedom of information disclosure relating to myeloma patients and the use of specific drugs used for treatment